The genetic analysis identified the TLR3 p.Pro554Ser variant in the patient, who experienced severe WNV encephalitis and severe COVID-19, and in his daughter, who had a mild COVID-19 infection, supporting an incomplete clinical penetrance. This evidence concerns the gene TLR3 and COVID-19.